CD23 Inhibitors

In the context of CD23 inhibitors, this term refers to agents that can reduce the activity or expression of CD23, a low-affinity receptor for IgE primarily found on B cells. CD23 plays a crucial role in allergic responses and is involved in B cell proliferation and differentiation. The chemical inhibitors of CD23 are not direct inhibitors but rather influence CD23 activity indirectly through the modulation of various immune-related pathways. Corticosteroids, for example, can reduce CD23 expression on B cells, thereby decreasing its function. Similarly, immunosuppressants like cyclosporine, mycophenolate mofetil, azathioprine, rapamycin, and tacrolimus can indirectly inhibit CD23 function by dampening the immune response, particularly T cell activity and B cell proliferation. Other compounds like methotrexate, leflunomide, hydroxychloroquine, and chloroquine also exert their effects through similar mechanisms. Interestingly, some compounds exert their inhibitory effects on CD23 through more specific molecular targets. For instance, leflunomide inhibits tyrosine kinases, which play a key role in B cell activity, thereby indirectly affecting CD23 function. Sulfasalazine inhibits NF-kB, a transcription factor that regulates CD23 expression.